ARCHIVES

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Six Compounds Carcinogenic, Risk to Humans, CH Subgroup Finds

February 2, 1979

Rescission Cuts $5-6 Mil. From NCI FY94 Appropriations , Affects Intramural Program

March 11, 1994

NCI Has Congressional Mandate Fr Planning Clinical Trials of Unconventional Therapies, Chabner Says

June 5, 1992

Keytruda Granted Approval In Metastatic Melanoma

September 26, 2014

NCI Director’s Office Gets Makeover In Reorganization Plan.

December 8, 2006

Thomas Tomasi Named New Director Of Roswell Park

June 27, 1986